Edit |   |
---|---|
Antigenic Specificity | FLT1, Human (Icrucumab biosimilar) |
Clone | Icrucumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human FLT1 Recombinant Antibody. Icrucumab (IMC-18F1) is a human monoclonal antibody designed for the treatment of solid tumors. Icrucumab was developed by ImClone Systems Inc. It is undergoing Phase I trials. |
Immunogen | n/a |
Other Names | Anti-FLT1 Recombinant Antibody, Research Grade Icrucumab, Anti-Human FLT1 Recombinant Antibody, 18F1, IMC-18F1, LY3012212, Antibody Drug Analogues, Monoclonal Antibody, YR1244, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1024603-92-6 |
Catalog # | YR1244 |
Price | please inquire |
Order / More Info | FLT1, Human (Icrucumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |